We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.36B
AUM Growth
-$501M
Cap. Flow
-$840M
Cap. Flow %
-10.05%
Top 10 Hldgs %
55.3%
Holding
88
New
16
Increased
20
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
VST icon
Vistra
VST
+$364M
2
CEG icon
Constellation Energy
CEG
+$243M
3
VTRS icon
Viatris
VTRS
+$109M
4
AKAM icon
Akamai
AKAM
+$98.7M
5
PRMB
Primo Brands
PRMB
+$67.1M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$217M
2
BAX icon
Baxter International
BAX
+$86M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$81.2M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$63.4M
5
COLL icon
Collegium Pharmaceutical
COLL
+$55.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.3%
2 Utilities 26.27%
3 Industrials 14.79%
4 Energy 5.36%
5 Financials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLN
1
Talen Energy Corp
TLN
$16.7B
$1.35B 16.15%
3,602,171
– –
FTAI icon
2
FTAI Aviation
FTAI
$22.2B
$728M 8.71%
3,700,000
+339,447
+10% +$57.8M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$41.2B
$667M 7.97%
21,355,510
-3,294,490
-13% -$81.2M
GLNG icon
4
Golar LNG
GLNG
$5.13B
$342M 4.08%
9,178,978
– –
VST icon
5
Vistra
VST
$47.4B
$323M 3.86%
+2,000,000
New +$364M
VTRS icon
6
Viatris
VTRS
$18.9B
$317M 3.8%
25,500,000
+10,115,000
+66% +$109M
ARQT icon
7
Arcutis Biotherapeutics
ARQT
$3.18B
$240M 2.87%
8,271,577
-2,477,880
-23% -$63.4M
CEG icon
8
Constellation Energy
CEG
$95.6B
$237M 2.83%
+670,000
New +$243M
TAC icon
9
TransAlta
TAC
$3.93B
$225M 2.69%
17,781,325
+1,832,874
+11% +$27.4M
ROIV icon
10
Roivant Sciences
ROIV
$26.2B
$195M 2.34%
9,000,000
-11,000,000
-55% -$217M
MCY icon
11
Mercury Insurance
MCY
$6.07B
$193M 2.31%
2,054,504
– –
BGC icon
12
BGC Group
BGC
$4.89B
$188M 2.24%
21,000,000
+3,000,000
+17% +$27M
FLR icon
13
Fluor
FLR
$7.96B
$164M 1.96%
4,143,808
-356,192
-8% -$15.8M
AMRX icon
14
Amneal Pharmaceuticals
AMRX
$5.79B
$155M 1.86%
12,334,941
– –
ZYME icon
15
Zymeworks
ZYME
$1.67B
$151M 1.81%
5,750,000
+1,039,449
+22% +$22.7M
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$5.93B
$137M 1.64%
3,328,653
-671,347
-17% -$26.9M
LBTYA icon
17
Liberty Global Class A
LBTYA
$3.6B
$112M 1.33%
10,018,432
+2,268,065
+29% +$25.1M
QDEL icon
18
QuidelOrtho
QDEL
$838M
$108M 1.29%
3,777,157
-860,581
-19% -$23.3M
AKAM icon
19
Akamai
AKAM
$15.9B
$105M 1.25%
+1,200,000
New +$98.7M
ECVT icon
20
Ecovyst
ECVT
$1.14B
$102M 1.22%
10,500,000
+100,000
+1% +$873K
CMPR icon
21
Cimpress
CMPR
$2.31B
$102M 1.21%
1,525,000
+344,211
+29% +$23.4M
IART icon
22
Integra LifeSciences
IART
$1.34B
$96.3M 1.15%
7,753,934
+100,000
+1% +$1.33M
DK icon
23
Delek US
DK
$3.58B
$79.7M 0.95%
2,687,449
– –
LILAK icon
24
Liberty Latin America Class C
LILAK
$1.64B
$79.5M 0.95%
11,722,629
+440,000
+4% +$3.29M
TDS icon
25
Telephone and Data Systems
TDS
$3.75B
$75.8M 0.91%
1,850,000
+250,000
+16% +$9.74M
1
2 3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2025 Portfolio in Review

As of Q4 2025, Rubric Capital Management (New York) held 88 positions worth $8.36B, down 5.7% from $8.86B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Rubric Capital Management (New York) withdrew a net $840M in Q4 2025, closing 12 positions and reducing 17 holdings. Its most notable exit was Baxter International, an estimated $86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Rubric Capital Management (New York) opened a new position in Vistra worth $323M.

  • Rubric Capital Management (New York)'s largest Q4 2025 buy was Vistra: 2,000,000 shares worth $323M.
  • Rubric Capital Management (New York) added most to Viatris in Q4 2025, an estimated $109M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $217M.
  • Rubric Capital Management (New York) fully exited Baxter International in Q4 2025, selling an estimated $86M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 55% of its $8.36B portfolio in Q4 2025.
  • Rubric Capital Management (New York) opened 16 new positions and closed 12 in Q4 2025.
  • Rubric Capital Management (New York)'s portfolio value fell 5.7% quarter-over-quarter to $8.36B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.